MHLW

Related by string. * * Japanese MHLW . Welfare MHLW *

Related by context. All words. (Click for frequent words.) 69 NESINA 64 Welfare MHLW 64 Devices Agency PMDA 61 Nippon Shinyaku 60 Shonin approval 59 Drug Administration KFDA 59 ANVISA 59 Pirespa 58 WHO prequalification 58 Rapinyl 58 Voraxaze 58 Preotact 58 Thalidomide Pharmion 58 Swissmedic 57 CHMP recommendation 57 Marketing Authorisation 57 Bayer Yakuhin 57 Inavir 57 FDAs 57 Orphan Drugs 57 Biologic License Application BLA 57 Alvesco R 57 Retacrit 57 Kissei Pharmaceutical 56 Kissei 56 Seikagaku Corporation 56 Marketing Authorisation Application 56 DC Bead 56 Nippon Kayaku 56 DCGI 56 Accelerated Assessment 56 liver resection surgeries 56 Centralised Procedure 56 Dexilant 56 Abstral ® 56 DrugAdministration 56 Marketing Authorization 56 Somatuline R Autogel R 56 balsalazide tablet 56 Erwinase 56 Velaglucerase Alfa 56 Torii Pharmaceutical 56 Marketing Authorization Applications 55 Morphine Sulfate 55 Urocidin TM 55 Marketing Authorisation Application MAA 55 Kyowa Hakko Kogyo 55 Premarket Approval 55 CLIA Waiver 55 Visian Toric ICL 55 BRILINTA 55 SYCREST 55 orphan designation 55 Cellegesic 55 PDUFA Prescription Drug 55 Dainippon Sumitomo 55 Japanese Encephalitis vaccine 55 casopitant 55 eprodisate Fibrillex TM 55 supplemental Biologics License Application 55 Asubio 55 Rectogesic 55 ORTHOVISC mini 55 Drug Submission 55 Teijin Pharma Limited 55 Plenaxis R 55 Glufast 55 ICH guidelines 55 Centralized Procedure 55 Teijin Pharma 54 Pirfenidone 54 Teysuno 54 Decentralized Procedure 54 cinacalcet HCl 54 CDSCO 54 Dainippon Pharmaceutical 54 TEMODAL 54 Advagraf 54 Shionogi 54 Tostrex 54 Zebinix R 54 BLAs 54 CryoSeal 54 Zensana 54 Arzerra ofatumumab 54 sublingual tablets 54 Deferiprone 54 methylnaltrexone bromide 54 Preotact R 54 Administration TGA 54 Marketing Authorizations 54 Expedited Review 54 Hexvix ® 54 User Fee Act 54 Biologics Licensing 54 Alogliptin 54 Abstral 54 subcutaneous RELISTOR 54 Therapeutic Goods Administration TGA 54 Sosei 54 Pre IND 54 CIP TRAMADOL ER 54 Alitretinoin 53 Firazyr 53 Kyorin Pharmaceutical 53 OMP designation 53 VALSTAR 53 Synerx 53 Takeda Pharma 53 Zenpep 53 Multiferon R 53 Onconase 53 Australian Therapeutic Goods 53 vinflunine 53 supplemental biologics 53 Otsuka Pharmaceuticals 53 BugOil R 53 telavancin NDA 53 EDQM 53 Cintredekin besudotox 53 Subpart E 53 Collategene 53 BLA filing 53 Application BLA 53 India DCGI 53 Biologic License Application 53 AFSSAPS 53 Act PDUFA date 53 Entocort 53 laninamivir 53 Amitiza lubiprostone 53 Fortovase 53 solifenacin succinate 53 Mycamine 53 Nabi HB Intravenous 53 OMAPRO ™ 53 PDUFA Date 53 CELVAPAN H#N# 53 Glucomed 53 Master File DMF 53 Civacir 53 Taiho 53 Emezine R 53 UMN Pharma 53 Fodosine 53 Mitsubishi Pharma 53 Trobalt 53 Medicinal Products EMEA 53 CLIA waiver 52 Yondelis ® 52 Anidulafungin 52 IND Investigational New 52 Files Investigational 52 Marketing Authorization Application MAA 52 Lubiprostone 52 Increlex TM 52 orphan medicinal 52 amifampridine phosphate 52 SEASONALE 52 Daewoong 52 Simulect 52 BEMA Fentanyl 52 Taiho Pharmaceutical 52 premarket notification 52 Gynazole 1 52 SymBio 52 Genzyme Myozyme 52 Bonefos 52 Glybera R 52 Serdolect ® 52 Alvesco ® 52 Amlodipine Besylate Tablets 52 Kyorin 52 Metformin Hydrochloride 52 Fast Track Status 52 injectable formulations 52 HepaGam B 52 novel oral anticoagulant 52 Tanabe Seiyaku 52 Sonolith i move 52 Firdapse 52 Commission JFTC 52 Hexvix 52 SEASONIQUE 52 DAIICHI SANKYO COMPANY LIMITED 52 Mutual Recognition Procedure 52 JCR Pharmaceuticals 52 ISO Vorin TM 52 Loramyc TM 52 TAXUS Element Stent System 52 Seiyaku 52 GTC recombinant form 52 New Drug Application 52 Kuhnil 52 FDA Accepts 52 Genetic Therapies Directorate 52 Febuxostat 52 enoxaparin sodium injection 52 Oracea ® 52 Sebivo 52 Marketing Authorization Application 52 BfArM 52 intravenous AAT 52 Resubmission 52 Biologics License Applications 52 Kaketsuken 52 Aloxi Injection 52 NerPharMa 52 nasal calcitonin product 52 Loramyc ™ 52 Anti Monopoly Law 52 granted Ortec 52 DEXILANT 52 apaziquone 52 Granted Orphan Drug 52 Clinical Trial Application 52 CONBRIZA 52 Product Monograph 52 Reclast Aclasta 52 Directorate TPD 52 Junovan 52 Bayer Yakuhin Ltd. 52 Product Characteristics 52 Esbriet pirfenidone 52 Rescula 52 European Medicines Evaluation 52 Orphan Drug status 52 USFDA 52 Loramyc R 52 Receives Marketing Authorization 52 Competent Authority 52 Drug Administration Oncologic Drugs 52 Nippon Soda 52 ZEFTERA ™ 52 Application MAA 52 Accelerated Approval 52 CE Marking 52 SFDA approval 52 Rotarix R 52 quinolone antibiotic 52 Solasia 52 Mepact 52 UPLYSO 52 Fast Track designations 52 Sanvar R 52 Approvable 52 cGMPs 51 Flutiform ™ 51 Chugai Pharmaceutical 51 Daiichi Pharmaceutical 51 Raptiva ® 51 RoActemra 51 Premarket Approval Application 51 Ropren 51 IV acetaminophen 51 Berinert 51 ARIXTRA R 51 BrachySil TM 51 Nebido 51 Roche Chugai 51 Teikoku Seiyaku 51 XIAFLEX ™ 51 FDA 51 Liprotamase 51 Flutiform TM 51 SNT MC# 51 rheumatoid arthritis Orencia 51 NIID 51 tramiprosate ALZHEMED TM 51 MEXT 51 pediatric exclusivity 51 Hiberix 51 Medicines Agency 51 Toyo Shinyaku 51 miconazole MBT 51 LGLS 51 Begin Clinical Trials 51 Ramelteon 51 FDA Modernization Act 51 Sancuso 51 BioNumerik 51 Evoltra ® 51 approvable letters 51 Raptiva R 51 Removab 51 Focetria 51 Orathecin 51 ULTRASE 51 PrandiMet 51 Hiroshi Tanaka 51 CRMD# 51 Sycrest 51 RAPIACTA ® 51 Amitiza ® 51 Combating Counterfeit Drugs 51 Evoltra 51 FIRAZYR 51 Tyzeka Sebivo 51 histamine dihydrochloride 51 NOXAFIL 51 Ciclesonide 51 Vitaros 51 ZEFTERA TM 51 sBLA 51 Toyama Chemical 51 Nihon Kohden Corporation 51 NEBIDO 51 Mitsubishi Tanabe 51 Silenor ® doxepin 51 cervical cancer vaccine Cervarix 51 KFDA 51 Velcade bortezomib 51 Clinical Trials Directive 51 indiplon capsules 51 Certican 51 Orphan Drug 51 Acurox r Tablets 51 RELISTOR ® 51 PMA Supplement 51 self affirmed GRAS 51 Somatuline Depot 51 Basilea Toctino R 51 Viviant 51 Tamsulosin 51 Taisho Pharmaceutical 51 Drug Eluting Stent System 51 Frova ® 51 Decentralized Procedure DCP 51 PREOS 51 SEASONALE R 51 AnGes MG 51 Chugai 51 MAA submission 51 Loramyc 51 Tech Ueno 51 Santen Pharmaceutical 51 Metozolv ODT 51 Orphan Drug designation 51 Dr. Flemming Ornskov 51 Sankyo 51 LHRH antagonist 51 Velac 51 Japanese Encephalitis Vaccine 51 application sNDA 51 Vantas 51 Plenaxis TM 51 SmPC 51 udenafil 51 Announces Tentative Approval 51 DRAXIMAGE 51 Clevudine 51 Suzuken 51 BiDil XR 51 Drug Administration FDA 51 Orphan Designation 51 Tracleer r 51 Vesicare 51 Helsinn Healthcare 51 Gestiva TM 50 CHMP opinion 50 Pegloticase 50 Oasmia 50 Oral Solution 50 Dacogen injection 50 SFDA 50 POSIDUR TM 50 Entecavir 50 Paragraph IV certifications 50 VivaGel ™ 50 eCTD format 50 FDA Approvable Letter 50 Meiji Seika 50 ThermoDox R 50 ONGLYZA ™ 50 ORENCIA ® 50 FACTIVE tablets 50 Complete Response 50 Ono Pharmaceutical 50 Auxilium Pharma 50 Zingo TM 50 ANDA Filing 50 Veterinary Medicines Directorate VMD 50 Amlodipine Besylate 50 Senju Pharmaceutical Co. 50 Risperidone Oral Solution 50 Kepivance 50 Filgrastim 50 Mochida 50 Glycopyrrolate 50 Irinotecan Hydrochloride Injection 50 inhaled AAT 50 SUTENT ® 50 Orphan Drug designations 50 Daiichi Suntory Pharma 50 Drug Submission NDS 50 Valtropin 50 European Medicines Agency 50 Onsolis 50 CoPP 50 Applications ANDA 50 Nivestim 50 Uracyst R 50 HuMax TAC 50 Pulmonary Allergy Drugs 50 Proprietary Medicinal Products 50 AERIUS 50 Aryplase 50 Rotarix ® 50 Premarket Notification 50 Rasagiline 50 DORIBAX 50 Troxatyl 50 miconazole Lauriad ® 50 Tanabe Seiyaku Co. 50 donepezil hydrochloride 50 Eisai 50 Receives Approvable Letter 50 Alferon N Injection 50 Arzerra TM 50 PROMUS Element Stent System 50 Kamada 50 REBETOL combination therapy 50 Mirapexin 50 Adenuric R 50 Kissei Pharmaceutical Co. 50 CGMP 50 IRESSA 50 Mimpara 50 Novel Foods 50 TYGACIL 50 SURFAXIN 50 MOVIPREP R 50 Telzir 50 Submits Supplemental 50 Biologics License Application 50 CE Marked 50 Imvamune 50 sNDAs 50 Toyo Bio 50 Telavancin 50 Dalbavancin 50 NDA Submission 50 Contrave NDA 50 Emezine 50 tolperisone 50 Shonin 50 ibuprofen Injection 50 Yakult Honsha Co. 50 Bazedoxifene 50 fipamezole 50 JFTC 50 Shin Poong 50 sNDA 50 Communications DDMAC 50 Intravenous Hepatitis B 50 Pennsaid R 50 ROTATEQ 50 ixabepilone 50 ELAPRASE 50 APF# NDA 50 Orphan Drug Status 50 Sanvar 50 Kynapid 50 Subpart H 50 orphan medicinal product 50 FDA approvable letter 50 oxymorphone ER 50 APTIMA HPV assay 50 ActiPatch Therapy 50 ICH E# 50 Supplemental Biologics License Application 50 Impavido R 50 Synerx Pharma 50 Biological License Application 50 Toctino ® 50 ATRIPLA TM 50 k Premarket Notification 50 Octreotide 50 Submits NDA 50 Kyowa Kirin 50 Periostat R 50 DAIICHI SANKYO 50 Daytrana ® 50 Vimpat ® lacosamide 50 MediBIC 50 IPM Wound Gel 50 Dermylex TM 50 ONSOLIS 49 Orphan designation 49 Otsuka Pharmaceutical 49 Joulferon 49 BEXXAR 49 single injection viscosupplement 49 Zavesca r 49 alogliptin 49 Cellcept 49 Movectro 49 Generic Versions 49 Chugai Pharmaceutical Co. 49 ARCOXIA 49 Handok Pharmaceuticals 49 Zelnorm Zelmac 49 rhLF 49 Kristalose ® lactulose 49 fluvoxamine maleate 49 Tekturna Rasilez 49 Veterinary Medicines Directorate 49 PLAVIX ® 49 dalbavancin 49 AnGes 49 Toctino R 49 Humenza 49 Tesamorelin 49 Revolade 49 Catena ® 49 Eloxatin ® 49 Xyrem ® 49 lucinactant 49 Prepandrix 49 Dainippon Sumitomo Pharma 49 No Objection Letter 49 GEM #S 49 Zegerid OTC 49 Ceplene ® histamine dihydrochloride 49 PhotoCure 49 LUMIGAN R 49 Teflaro 49 postapproval 49 levocetirizine 49 guanfacine extended release 49 Pharmacopoeia USP 49 Lambert Eaton Myasthenic 49 Nascobal Nasal Spray 49 Glassia 49 PREVU x POC 49 Clexane R 49 Pfizer maraviroc 49 Peramivir 49 Topiramate Tablets 49 Efient 49 Extended Release 49 Angiox 49 Receives Orphan Drug Designation 49 pitavastatin 49 Compulsory Licensing 49 FDA Advisory Panel 49 Fentanyl TAIFUN R 49 Enhanze SC 49 BARACLUDE R 49 Clindesse TM 49 Oracea TM 49 USFDA approval 49 daptomycin 49 TQT study 49 License Option Agreement 49 Kwang Dong 49 AMITIZA ® 49 Cerepro ® 49 Renvela ® 49 Orphan Status 49 pixantrone NDA 49 UCB Cimzia 49 THALOMID 49 IND Application 49 Emend 49 Orphan Medicinal Product 49 Arranon 49 Cetrotide R 49 BAL# [002] 49 CDER 49 Fortigel 49 Takeda 49 Vimpat R 49 Prexige lumiracoxib 49 RhuDex 49 FDA Orphan Drug 49 Stedesa 49 HCl capsules 49 Dabigatran etexilate 49 Humira adalimumab 49 Divalproex Sodium 49 Eiken Chemical 49 pancreatic enzyme 49 postmarket surveillance 49 Satraplatin 49 ZaBeCor 49 Olmesartan 49 Fusilev 49 palonosetron 49 Devices Advisory Panel 49 Exocrine Pancreatic Insufficiency 49 Seikagaku 49 UCB Keppra 49 Controls CMC 49 Captisol enabled 49 Monovisc 49 biogeneric drugs 49 XIAFLEX ® 49 Orexo 49 Notified Bodies 49 Biologics License Application BLA 49 Postmarket 49 Surfaxin lucinactant 49 Requip XL 49 Omacor ® 49 Product Designation 49 Icatibant 49 Tamibarotene 49 JECFA 49 orphan drug 49 Thelin TM 49 Pariet 49 Maleate 49 Pronova 49 StemEx R 49 Teva Provides Update 49 Erythropoiesis Stimulating Agents ESAs 49 rotigotine transdermal patch 49 biosimilar filgrastim 49 reslizumab 49 PDUFA date 49 intravenous acetaminophen 49 ATL# [002] 49 ZEGERID Chewable Tablets 49 FDA Dermatologic 49 Desvenlafaxine 49 PMPRB 49 Egrifta 49 Lupin Pharmaceuticals 49 PrevOnco ™ 49 DAYTRANA TM 49 NMEs 49 Gleevec Glivec 49 INDs 49 OvaDx 48 GRAS notification 48 Linjeta TM 48 Yakult Honsha 48 InvaGen 48 intravenous iv peramivir 48 Generic Version Of 48 rasagiline tablets 48 Aceon 48 Increlex R 48 successfully commercialize Iluvien 48 sublingual fentanyl 48 Sucampo 48 pancreatic enzyme replacement 48 Investigational Device Exemption 48 CERVARIX R 48 Doribax 48 Lurasidone 48 Rasilez HCT 48 cethromycin NDA 48 Tramadol ER 48 Fentanyl Taifun 48 Taisho Pharmaceutical Co. 48 Marketing Authorisations 48 Proprietary Medicinal Products CPMP 48 Medsafe 48 Omnitrope 48 FlutiformTM 48 Shire BioChem Inc. 48 Uracyst ® 48 Oncolys 48 Kitasato 48 Amgen Nplate 48 Somatuline Autogel 48 Lodotra 48 Antimonopoly Act 48 Use Authorization EUA 48 ADDERALL XR R 48 Ixempra 48 RhuDex ® 48 Betaseron ® 48 rThrombin 48 Gestiva ™ 48 Premarket Approval PMA 48 Polyphenon ® E 48 TKPHF 48 OFIRMEV 48 SEBIVO 48 cathepsin K inhibitor 48 Zalbin 48 Roflumilast 48 Mofcom 48 Orazol 48 Cellegesic TM nitroglycerin ointment 48 Sankyo Co. 48 vaccine Synflorix 48 Rapydan 48 DepoDur 48 Grünenthal GmbH 48 #k Clearance 48 Evoltra TM 48 topical NSAID 48 Zavesca R 48 Praecis 48 PrandiMet TM 48 TaiGen 48 Teikoku Pharma USA 48 Argatroban 48 Ozurdex 48 Menaflex implant 48 KRYSTEXXA TM 48 Submits Response 48 Drug Administration FDA Oncologic 48 Taiho Pharmaceutical Co. 48 AstraZeneca Symbicort 48 Drug Application 48 Kiacta 48 Edoxaban 48 Oncologic Drugs Advisory 48 Initiate Clinical Trial 48 Asahi Kasei Pharma 48 Veregen ® 48 Cefazolin 48 TELEC 48 Mucotrol 48 DPCO 48 Nippon Chemiphar 48 Diamyd r 48 oral methylnaltrexone 48 Meiji Seika Kaisha Ltd. 48 GTC recombinant human 48 Powerlink System 48 Relistor 48 Onalta 48 rolling Biologics License 48 TWYNSTA ® 48 Evoltra R 48 LidoPAIN SP 48 Investigational Drugs 48 Medidur TM FA 48 GMP Certification 48 IND submission 48 IDE Investigational Device Exemption 48 Merck RotaTeq 48 Actonel ® 48 WTO TRIPS Agreement 48 Barr ANDA 48 Metoprolol Succinate 48 CPMP 48 CORTOSS Bone Augmentation Material 48 ECVAM 48 TAKEDA 48 Zavesca 48 USDA FSIS 48 PRIALT 48 Ofirmev 48 Therapeutic Products 48 KIACTA ™ 48 vismodegib 48 Vidaza azacitidine 48 investigational hepatitis B 48 EXALGO 48 Phenoptin 48 ZURICH AFX Novartis AG 48 EGRIFTA TM 48 Onrigin 48 assigned PDUFA 48 Sutent sunitinib 48 Allegra Oral Suspension 48 Scientific Advice 48 Clofarabine 48 Fabry Disease 48 CAPHOSOL 48 Suprax 48 StaphVAX R 48 BLA submission 48 Rheoscience 48 INTUNIV TM 48 Orapred ODT 48 FDA Anti Infective 48 Intercell vaccine 48 Biosimilar 48 Peginterferon alfa 2b 48 taliglucerase alfa 48 ProUroScan 48 Synvisc ONE 48 Eucreas 48 GRAS affirmation 48 darbepoetin alfa Aranesp 48 Securite Sanitaire des Produits 48 octagam ® 48 Zyflo CR 48 Keppra ® XR 48 Ranbaxy Paonta Sahib 48 gabapentin enacarbil 48 THELIN 48 Æterna Zentaris 48 CryoSeal FS System 48 Ophthalmic Drugs Advisory 48 IoGen 48 Saforis 48 Wellbutrin XL R 48 Kapidex 48 Romiplostim 48 Urocidin 48 Use Authorization 48 BioGlue ® 48 PMA submission 48 ezogabine 48 AdreView 48 LIALDA 48 FDA Antiviral Drugs 48 Xolegel 48 Eligard ® 48 pulls Darvon painkiller 48 Actemra tocilizumab 48 MEPACT 48 Approvable letter 48 Campto 48 Tamiflu oseltamivir phosphate 48 Mycograb 48 AMITIZA R 48 ATPace TM 48 Adenuric 48 FIRMAGON R 48 ZEGERID Powder 48 LUCASSIN 48 BLP# Liposome Vaccine 48 FDAâ € ™ 48 Bayer Onyx 48 Focalin XR R 48 METOZOLV ODT 48 AstraZeneca Toprol XL 48 Phase III Clinical Trial 48 Methylphenidate Transdermal System 48 Teikoku Seiyaku Co. 48 Adenuric ® 48 Cefprozil 48 Loramyc ® 48 MoEA 48 Receives Tentative FDA 48 ANDA filings 48 Fast Track Designation 48 Neovasc Reducer 48 Pharmacopeia USP 48 Virulizin R 48 Vernakalant 48 Proquin XR 48 Angiox ® 48 Daiichi Sankyo 48 MK #B 48 Cladribine 48 Pharmacopeial Convention 48 ZEVALIN ® 48 fentanyl transdermal system 48 Bifeprunox 48 Troxatyl TM 48 Yozan 48 Uloric 48 Cefepime 48 ELIQUIS 48 ZEGERID Capsules 48 Taisho Pharmaceuticals 48 Valganciclovir 48 PrevOnco 48 Reloxin R 47 Rhucin R 47 Zirgan 47 Janssen Ortho Inc. 47 Janssen Pharmaceutical 47 pioglitazone HCl 47 SILENOR 47 Eraxis 47 voclosporin 47 Drug Controller 47 Targretin capsules 47 ReFacto 47 eribulin mesylate 47 FACTIVE R gemifloxacin 47 Pennsaid Plus 47 Pivotal Phase III 47 Vectibix panitumumab 47 Calcium Acetate 47 ZEFTERA TM Zevtera TM 47 IXIARO 47 lubiprostone 47 authority Gurian Sherman 47 NDA resubmission 47 Injectafer 47 CODEX 47 Rasilamlo 47 Firazyr ® 47 DYNEPO 47 XAGRID 47 Drugs Controller 47 Yamanouchi Pharmaceutical Co. 47 Aclasta Reclast 47 Takahagi 47 REPLAGAL 47 Medicines Consortium 47 Patanase 47 IXIARO ® 47 DNAwithPap TM Test 47 Afinitor everolimus 47 Dyloject TM 47 Sanofi Acomplia 47 MDUFMA 47 Cefprozil tablets 47 Citizen Petition 47 Q#IR 47 HalcyGen 47 Grünenthal 47 PEG INTRON 47 methylnaltrexone 47 Trovax 47 GlucaGen 47 Fortical R 47 Shanghai Wanxing 47 FDAAA 47 Bioresearch Monitoring 47 Uvidem 47 EOquin 47 GRALISE 47 MONOVISC 47 capsule formulation 47 Vitrasert R 47 Phase III Clinical Trials 47 Salix Pharma 47 ThermoDox ® 47 SCHWARZ PHARMA 47 Mitsubishi Tanabe Pharma 47 Zolpimist 47 Humanitarian Device Exemption 47 Patent Upheld 47 Certolizumab pegol 47 lurasidone 47 Functional Dyspepsia 47 received CE Conformite 47 Antigen CEA 47 National Coverage Determination 47 VIVITROL ® 47 Sunesis Pharma 47 Akzo Nobel Organon 47 FDA Accelerated Approval 47 CHMP 47 satraplatin 47 Amgen Vectibix 47 transcervical sterilization 47 Tokyo JCNN 47 Keppra XR 47 octreotide acetate 47 highly purified pasteurized 47 ALVESCO R 47 Uplyso 47 GATTEX TM 47 Receives Positive Opinion 47 Generally Recognized As 47 cSSTI 47 Grants Orphan Drug 47 FDA Approvals 47 Hycamtin 47 Atelvia 47 Carbidopa Levodopa 47 FSSAI 47 Oncolys BioPharma 47 DaTSCAN 47 Drug Administration USFDA 47 Zemplar 47 Takara Bio 47 Friedreich Ataxia FRDA 47 ANDA applicant 47 Levoleucovorin 47 Simponi golimumab 47 Lilly Strattera 47 HepeX B 47 Nascobal 47 silodosin 47 AstraZeneca Toprol 47 Notified Body 47 Tolvaptan 47 DPX Survivac 47 Soliris TM eculizumab 47 Orphan Drug Designation 47 Botox Botox Cosmetic 47 Fludara ® 47 rADTZ 47 EHPM 47 TOPROL XL 47 ISTODAX 47 Fresenius Biotech 47 cefuroxime axetil 47 Sysmex Corporation 47 alvimopan 47 MEZAVANT 47 Positive Opinion 47 IPLEX 47 Avastin bevacizumab 47 Bendamustine 47 Gentamicin Surgical Implant 47 Fondaparinux 47 Noxafil 47 NOIP 47 Ecallantide 47 Meda STO MEDAA 47 Luveris

Back to home page